Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bast

Showing results (241-250 of 560) with videos related to

Pageof 56
Sort By:
Cell Death and Differentiation|April 29, 2014
ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7Z Lu, H Yang, M N Sutton, et al.
American Journal of Obstetrics and Gynecology|October 1, 1990
The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreductionV J Hunter, L Daly, M Helms, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1995
Molecular approaches to prevention and detection of epithelial ovarian cancerR C Bast, C M Boyer, F J Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1982
Bystander suppression of tumor growth: evidence that specific targets and bystanders are damaged by injury to a common microvasculatureS J Galli, R C Bast, B S Bast, et al.
Endocrine-Related Cancer|April 13, 2013
FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3Xiang Tao, Naiqing Zhao, Hongyan Jin, et al.
Epigenetics|October 19, 2013
Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinomaTianjiao Lyu, Nan Jia, Jieyu Wang, et al.
International Journal of Cancer|September 11, 2019
SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promotersTianjiao Lyu, Yahui Jiang, Nan Jia, et al.
Cancer Research|August 15, 1989
Elimination of malignant clonogenic breast cancer cells from human bone marrowI C Anderson, E J Shpall, D S Leslie, et al.
International Journal of Cancer|January 15, 1987
Co-expression of human cancer-associated epitopes on mucin moleculesM S Lan, R C Bast, M I Colnaghi, et al.
Cancers|November 15, 2018
Cell Origins of High-Grade Serous Ovarian CancerJaeyeon Kim, Eun Young Park, Olga Kim, et al.
Pageof 56

Showing results (241-250 of 560) with videos related to

Sort By:
Pageof 56
Cell Death and Differentiation|April 29, 2014
ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7Z Lu, H Yang, M N Sutton, et al.
American Journal of Obstetrics and Gynecology|October 1, 1990
The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreductionV J Hunter, L Daly, M Helms, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1995
Molecular approaches to prevention and detection of epithelial ovarian cancerR C Bast, C M Boyer, F J Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1982
Bystander suppression of tumor growth: evidence that specific targets and bystanders are damaged by injury to a common microvasculatureS J Galli, R C Bast, B S Bast, et al.
Endocrine-Related Cancer|April 13, 2013
FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3Xiang Tao, Naiqing Zhao, Hongyan Jin, et al.
Epigenetics|October 19, 2013
Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinomaTianjiao Lyu, Nan Jia, Jieyu Wang, et al.
International Journal of Cancer|September 11, 2019
SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promotersTianjiao Lyu, Yahui Jiang, Nan Jia, et al.
Cancer Research|August 15, 1989
Elimination of malignant clonogenic breast cancer cells from human bone marrowI C Anderson, E J Shpall, D S Leslie, et al.
International Journal of Cancer|January 15, 1987
Co-expression of human cancer-associated epitopes on mucin moleculesM S Lan, R C Bast, M I Colnaghi, et al.
Cancers|November 15, 2018
Cell Origins of High-Grade Serous Ovarian CancerJaeyeon Kim, Eun Young Park, Olga Kim, et al.
Pageof 56